LNAI — Lunai Bioworks Cashflow Statement
0.000.00%
Last trade - 00:00- $25.07m
- $26.60m
Annual cashflow statement for Lunai Bioworks, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.7 | -113 | -39.7 | -80.7 | -178 |
| Depreciation | |||||
| Non-Cash Items | 5.06 | 96.2 | 23.5 | 60.7 | 164 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.932 | 1.42 | 4.31 | 8.81 | 5.86 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -20.6 | -15.7 | -11.8 | -11 | -7.87 |
| Capital Expenditures | -0.049 | -0.005 | -0.03 | -0.07 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -1.19 | -0.5 |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.049 | -0.005 | -0.03 | -1.26 | -0.5 |
| Financing Cash Flow Items | 28.1 | 4.68 | 4.01 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 32.6 | 4.25 | 4.52 | 10.5 | 8.38 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12 | -11.5 | -7.3 | -1.65 | -0.128 |